Related Experiment Videos

Dysglycemia, not just diabetes, is a continuous risk factor for cardiovascular disease

H C Gerstein

    Evidence-Based Cardiovascular Medicine
    |December 29, 2005
    PubMed

    Insights

    Dysglycemia, or abnormal blood glucose levels, is a cardiovascular risk factor. Ongoing studies will determine if lowering glucose reduces cardiovascular risk, potentially offering new strategies for cardiovascular disease prevention.

    Area of Science:

    • Endocrinology
    • Cardiology
    • Metabolic Syndrome

    Background:

    • Dysglycemia represents a spectrum of glucose regulation abnormalities.
    • Elevated glucose levels, even in non-diabetic individuals, are increasingly recognized as a significant cardiovascular risk factor.
    • The precise impact of glucose-lowering interventions on cardiovascular outcomes requires further investigation.

    Discussion:

    • The continuous relationship between glycemia and cardiovascular risk suggests that interventions targeting glucose may be beneficial.
    • Ongoing clinical trials are crucial for elucidating the efficacy of glucose-lowering strategies in diverse populations.
    • Understanding the cardiovascular implications of non-diabetic dysglycemia opens avenues for novel preventative approaches.

    Key Insights:

    • Dysglycemia is a continuous risk factor for cardiovascular disease (CVD).
    • The benefit of glucose-lowering interventions on cardiovascular risk is currently under investigation.
    • Non-diabetic glucose levels are associated with increased CVD risk.

    Outlook:

    • Future research will focus on the results of ongoing studies to confirm the cardiovascular benefits of glucose control.
    • Identifying and managing dysglycemia in pre-diabetic and non-diabetic individuals may become a key strategy in CVD prevention.
    • Personalized approaches to glucose management could optimize cardiovascular health.

    Related Concept Videos

    Complications of Diabetes Mellitus01:22

    Complications of Diabetes Mellitus

    Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
    Hyperglycemia01:29

    Hyperglycemia

    Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
    Diabetes Mellitus: Type 2 and Gestational01:22

    Diabetes Mellitus: Type 2 and Gestational

    Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
    Hypoglycemia01:26

    Hypoglycemia

    Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
    Type II Diabetes I: Introduction01:26

    Type II Diabetes I: Introduction

    Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
    Pathophysiology of Diabetes01:20

    Pathophysiology of Diabetes

    Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
    Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...